Ziphius` mission is to reduce the global impact of infectious diseases on global health care by creating a new generation of transformative vaccines.

Based in Belgium, Ziphius` team is composed of 24 members. This is expected to grow exponentially over the next years. Ziphius` team is managed by a team of highly dedicated experts, with a strong scientific, managerial and pharmaceutical background.

To uncover the possibilities of self-amplifying RNA as prophylactic vaccines against infectious diseases and therapeutics for rare genetic disorders.

Gamechangers

We address public health needs by developing a self-amplifying RNA-based platform for rapid and scalable manufacturing of innovative medical tools.

Ziphius Vaccines NV Downloads

Dual-Antigen Self-Amplifying RNA SARS-Cov-2 Vaccine- Brochure - Brochure

Contact supplier